CVS Health
CVS
1,270 hedge funds and large institutions have $74.3B invested in CVS Health in 2014 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 456 increasing their positions, 562 reducing their positions, and 45 closing their positions.
91% more first-time investments, than exits
New positions opened: 86 | Existing positions closed: 45
41% more call options, than puts
Call options by funds: $246M | Put options by funds: $175M
3% more funds holding
Funds holding: 1,236 → 1,270 (+34)
0.41% less ownership
Funds ownership: 84.33% → 83.93% (-0.41%)
1% less capital invested
Capital invested by funds: $74.9B → $74.3B (-$596M)
14% less funds holding in top 10
Funds holding in top 10: 141 → 121 (-20)
19% less repeat investments, than reductions
Existing positions increased: 456 | Existing positions reduced: 562
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$716M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$249M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$190M |
| 4 |
JP Morgan Chase
New York
|
+$161M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$122M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.01B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$344M |
| 3 |
Lazard Asset Management
New York
|
-$240M |
| 4 |
DSA
Davis Selected Advisers
Tucson,
Arizona
|
-$183M |
| 5 |
VAM
Visium Asset Management
New York
|
-$122M |
CVS Hedge Fund Activity: Q2 2014 in Review
1,270 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q2 2014, worth a combined $74.3B — down 0.8% from $74.9B a quarter earlier.
Buyers outnumbered sellers: 86 funds opened new CVS positions and 45 closed out — a net gain of 41 holders — while 456 added to existing stakes and 562 trimmed.
The largest buyer was Norges Bank, adding an estimated $716M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $1.01B sold.
- 1,270 institutional investors held CVS Health (CVS) as of Q2 2014, up from 1,236 in Q1 2014.
- Funds reported $74.3B of CVS Health stock for Q2 2014, down 0.8% quarter-over-quarter.
- 86 funds opened new CVS Health positions in Q2 2014 and 45 closed out, a net change of +41 holders.
- The largest CVS Health buyer in Q2 2014 was Norges Bank, an estimated $716M added.
- The largest CVS Health seller in Q2 2014 was Capital Research Global Investors, an estimated $1.01B sold.
Based on aggregated 13F filings for Q2 2014.